Published in Ageing Res Rev on February 03, 2014
Age-related neurodegenerative disease research needs aging models. Front Aging Neurosci (2015) 0.93
Interplay between Metabolism and Epigenetics: A Nuclear Adaptation to Environmental Changes. Mol Cell (2016) 0.93
Parkinson's disease as a result of aging. Aging Cell (2015) 0.92
Integration of 'omics' data in aging research: from biomarkers to systems biology. Aging Cell (2015) 0.88
Eryptosis as a marker of Parkinson's disease. Aging (Albany NY) (2014) 0.86
mHealth For Aging China: Opportunities and Challenges. Aging Dis (2016) 0.86
Neuroprotective Effects of A Standardized Flavonoid Extract of Safflower Against Neurotoxin-Induced Cellular and Animal Models of Parkinson's Disease. Sci Rep (2016) 0.83
Lithium prevents parkinsonian behavioral and striatal phenotypes in an aged parkin mutant transgenic mouse model. Brain Res (2014) 0.83
The epigenetic role of vitamin C in health and disease. Cell Mol Life Sci (2016) 0.83
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications. Neurotherapeutics (2015) 0.81
Appraising the Role of Iron in Brain Aging and Cognition: Promises and Limitations of MRI Methods. Neuropsychol Rev (2015) 0.81
The degeneration and replacement of dopamine cells in Parkinson's disease: the role of aging. Front Neuroanat (2014) 0.80
Selective neuronal vulnerability in Parkinson disease. Nat Rev Neurosci (2017) 0.79
Bent out of shape: α-Synuclein misfolding and the convergence of pathogenic pathways in Parkinson's disease. FEBS Lett (2015) 0.78
Association of TLR4 gene polymorphisms with sporadic Parkinson's disease in a Han Chinese population. Neurol Sci (2015) 0.77
Elevated α-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson's patient-derived induced pluripotent stem cells. Cell Death Dis (2015) 0.77
Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson's Disease. Biomolecules (2015) 0.77
Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease. J Neurochem (2016) 0.77
Interaction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease. Biomolecules (2015) 0.77
Immunomodulators as Therapeutic Agents in Mitigating the Progression of Parkinson's Disease. Brain Sci (2016) 0.77
Expression of Iron Transporters and Pathological Hallmarks of Parkinson's and Alzheimer's Diseases in the Brain of Young, Adult, and Aged Rats. Mol Neurobiol (2016) 0.76
Possible role of Epoxyeicosatrienoic acid in prevention of oxidative stress mediated neuroinflammation in Parkinson disorders. Med Hypotheses (2016) 0.75
Association of Dopamine Beta-Hydroxylase (DBH) Polymorphisms with Susceptibility to Parkinson's Disease. Med Sci Monit (2016) 0.75
A novel mouse model of the aged brain: Over-expression of the L-type voltage-gated calcium channel CaV1.3. Behav Brain Res (2016) 0.75
Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson's disease. Sci Rep (2017) 0.75
Neuroprotective effects of porphyran derivatives against 6-hydroxydopamine-induced cytotoxicity is independent on mitochondria restoration. Ann Transl Med (2015) 0.75
Serotonergic system in hypoxic ventilatory response in unilateral rat model of Parkinson's disease. J Biomed Sci (2017) 0.75
Orphan proteins of unknown function in the mitochondrial intermembrane space proteome: New pathways and metabolic cross-talk. Biochim Biophys Acta (2016) 0.75
Systems biology of neurodegenerative diseases. Integr Biol (Camb) (2015) 0.75
Genome-wide analysis of DNA methylation during antagonism of DMOG to MnCl2-induced cytotoxicity in the mouse substantia nigra. Sci Rep (2016) 0.75
Back to the tubule: microtubule dynamics in Parkinson's disease. Cell Mol Life Sci (2016) 0.75
Aceruloplasminemia With Psychomotor Excitement and Neurological Sign Was Improved by Minocycline (Case Report). Medicine (Baltimore) (2016) 0.75
Effect of aging on stem cells. World J Exp Med (2017) 0.75
Drosophila Clock Is Required in Brain Pacemaker Neurons to Prevent Premature Locomotor Aging Independently of Its Circadian Function. PLoS Genet (2017) 0.75
Differences in vulnerability of neurons and astrocytes to heme oxygenase-1 modulation: Implications for mitochondrial ferritin. Sci Rep (2016) 0.75
Segmental Aging Underlies the Development of a Parkinson Phenotype in the AS/AGU Rat. Cells (2016) 0.75
The Effects of Crocin on 6-OHDA-Induced Oxidative/Nitrosative Damage and Motor Behaviour in Hemiparkinsonian Rats. Malays J Med Sci (2016) 0.75
G2019S LRRK2 and aging confer susceptibility to proteasome inhibitor-induced neurotoxicity in nigrostriatal dopaminergic system. J Neural Transm (Vienna) (2015) 0.75
Metabolic Investigations of the Molecular Mechanisms Associated with Parkinson's Disease. Metabolites (2017) 0.75
Age-Related Decline in the Variation of Dynamic Functional Connectivity: A Resting State Analysis. Front Aging Neurosci (2017) 0.75
Autophagy and Its Impact on Neurodegenerative Diseases: New Roles for TDP-43 and C9orf72. Front Mol Neurosci (2017) 0.75
The Treadmill Exercise Protects against Dopaminergic Neuron Loss and Brain Oxidative Stress in Parkinsonian Rats. Oxid Med Cell Longev (2017) 0.75
Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature (2006) 24.39
Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem (2006) 22.87
Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature (2006) 21.40
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J (2008) 12.89
Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature (2006) 11.91
Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature (2004) 11.59
Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci (2000) 10.62
Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature (2008) 9.66
Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science (1983) 9.41
Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain (1991) 8.16
Epidemiology of Parkinson's disease. Lancet Neurol (2006) 8.13
Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc Natl Acad Sci U S A (2003) 7.57
Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res (2004) 7.06
alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol (2002) 6.64
High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet (2006) 6.52
Autophagy and aging. Cell (2011) 5.96
Mitochondrial complex I deficiency in Parkinson's disease. Lancet (1989) 5.72
Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science (2000) 5.62
'Rejuvenation' protects neurons in mouse models of Parkinson's disease. Nature (2007) 5.03
Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet (2006) 4.61
Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem (1990) 4.03
Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J Neurosci (2000) 3.90
Alzheimer's disease and Parkinson's disease. N Engl J Med (2003) 3.88
Mitochondrial DNA mutations in human colonic crypt stem cells. J Clin Invest (2003) 3.84
Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Histopathol (1997) 3.80
Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nat Genet (1992) 3.53
Neocortical neuron number in humans: effect of sex and age. J Comp Neurol (1997) 3.49
Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet (2003) 3.39
Axonal mitochondrial transport and potential are correlated. J Cell Sci (2004) 3.15
DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy. Hum Mol Genet (2010) 3.00
Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet (2004) 2.91
Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J Biol Chem (2008) 2.86
Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J Neurosci (2006) 2.85
Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons. Proc Natl Acad Sci U S A (2007) 2.77
What causes mitochondrial DNA deletions in human cells? Nat Genet (2008) 2.70
Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy. J Neuropathol Exp Neurol (2006) 2.57
Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem (2008) 2.53
Nigral pathology and parkinsonian signs in elders without Parkinson disease. Ann Neurol (2012) 2.52
Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J Neurochem (1989) 2.44
Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease. Trends Neurosci (2007) 2.39
Pink1 forms a multiprotein complex with Miro and Milton, linking Pink1 function to mitochondrial trafficking. Biochemistry (2009) 2.38
Random intracellular drift explains the clonal expansion of mitochondrial DNA mutations with age. Am J Hum Genet (2001) 2.31
The pedunculopontine nucleus and Parkinson's disease. Brain (2000) 2.21
Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain. Nat Genet (1992) 2.16
Chaperone-mediated autophagy markers in Parkinson disease brains. Arch Neurol (2010) 2.12
The PINK1-Parkin pathway promotes both mitophagy and selective respiratory chain turnover in vivo. Proc Natl Acad Sci U S A (2013) 2.10
Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein. J Biol Chem (2011) 1.96
Impaired autophagosome clearance contributes to cardiomyocyte death in ischemia/reperfusion injury. Circulation (2012) 1.91
Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content? J Neurochem (1992) 1.91
Altered proteasomal function in sporadic Parkinson's disease. Exp Neurol (2003) 1.91
MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping. Neuroimage (2011) 1.87
Proteasomal dysfunction in aging and Huntington disease. Neurobiol Dis (2010) 1.85
The PINK1-Parkin pathway is involved in the regulation of mitochondrial remodeling process. Biochem Biophys Res Commun (2008) 1.84
Impaired mitochondrial transport and Parkin-independent degeneration of respiratory chain-deficient dopamine neurons in vivo. Proc Natl Acad Sci U S A (2011) 1.82
Depletion of 26S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies. J Neurosci (2008) 1.79
Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. Hum Mol Genet (2001) 1.74
Proteasomal function is impaired in substantia nigra in Parkinson's disease. Neurosci Lett (2001) 1.73
Mitochondrial DNA deletions inhibit proteasomal activity and stimulate an autophagic transcript. Free Radic Biol Med (2006) 1.73
Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J Neurochem (1991) 1.70
Calcium entry induces mitochondrial oxidant stress in vagal neurons at risk in Parkinson's disease. Nat Neurosci (2012) 1.70
Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J Neurol Neurosurg Psychiatry (1991) 1.69
Pacemaking in dopaminergic ventral tegmental area neurons: depolarizing drive from background and voltage-dependent sodium conductances. J Neurosci (2010) 1.66
The function of α-synuclein. Neuron (2013) 1.63
Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. Proc Natl Acad Sci U S A (1987) 1.62
Understanding the molecular causes of Parkinson's disease. Trends Mol Med (2006) 1.62
Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD. Ann Neurol (2005) 1.62
Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. Ann Neurol (2010) 1.60
The impact of pathogenic mitochondrial DNA mutations on substantia nigra neurons. J Neurosci (2013) 1.59
Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient. Brain Pathol (2008) 1.52
Mitochondrial membrane potential in axons increases with local nerve growth factor or semaphorin signaling. J Neurosci (2008) 1.51
Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2. Neurology (2010) 1.48
Drosophila DJ-1 mutants show oxidative stress-sensitive locomotive dysfunction. Gene (2005) 1.46
Mitochondrial association of alpha-synuclein causes oxidative stress. Cell Mol Life Sci (2008) 1.45
Α-synuclein misfolding and Parkinson's disease. Biochim Biophys Acta (2011) 1.43
Mitochondrial myopathy, parkinsonism, and multiple mtDNA deletions in a Sephardic Jewish family. Neurology (2001) 1.43
Mitofusin 2 is necessary for striatal axonal projections of midbrain dopamine neurons. Hum Mol Genet (2012) 1.42
α-Synuclein oligomers and clinical implications for Parkinson disease. Ann Neurol (2012) 1.42
Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. N Engl J Med (1983) 1.40
Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics. Biochim Biophys Acta (2011) 1.32
Monitoring autophagic flux by an improved tandem fluorescent-tagged LC3 (mTagRFP-mWasabi-LC3) reveals that high-dose rapamycin impairs autophagic flux in cancer cells. Autophagy (2012) 1.32
Early-onset familial parkinsonism due to POLG mutations. Ann Neurol (2006) 1.31
The role of the locus coeruleus in the development of Parkinson's disease. Neurosci Biobehav Rev (2000) 1.31
Dopaminergic midbrain neurons are the prime target for mitochondrial DNA deletions. J Neurol (2008) 1.28
Mechanism of neurodegeneration of neurons with mitochondrial DNA mutations. Brain (2010) 1.27
Binding of iron to neuromelanin of human substantia nigra and synthetic melanin: an electron paramagnetic resonance spectroscopy study. Free Radic Biol Med (1997) 1.23
Cell-produced alpha-synuclein oligomers are targeted to, and impair, the 26S proteasome. Neurobiol Aging (2008) 1.23
Parkinson's disease-associated DJ-1 mutations impair mitochondrial dynamics and cause mitochondrial dysfunction. J Neurochem (2012) 1.19
Morphometry of the human substantia nigra in ageing and Parkinson's disease. Acta Neuropathol (2008) 1.18
Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease. Cell Death Dis (2013) 1.17
Cerebellar ataxia in patients with mitochondrial DNA disease: a molecular clinicopathological study. J Neuropathol Exp Neurol (2012) 1.17
Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease. Biochim Biophys Acta (2011) 1.16
Alpha-synuclein overexpression and aggregation exacerbates impairment of mitochondrial functions by augmenting oxidative stress in human neuroblastoma cells. Int J Biochem Cell Biol (2009) 1.15
Mutation of the linker region of the polymerase gamma-1 (POLG1) gene associated with progressive external ophthalmoplegia and Parkinsonism. Arch Neurol (2007) 1.13
The comparative biology of neuromelanin and lipofuscin in the human brain. Cell Mol Life Sci (2008) 1.13
alpha-synuclein immunopositive Parkinson's disease-related inclusion bodies in lower brain stem nuclei. Acta Neuropathol (2001) 1.12
Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease. Brain (2005) 1.12
The role of α-synuclein in neurotransmission and synaptic plasticity. J Chem Neuroanat (2010) 1.11
Mitochondrial DNA polymorphisms and risk of Parkinson's disease in Spanish population. J Neurol Sci (2005) 1.10
Correlation of putative iron content as represented by changes in R2* and phase with age in deep gray matter of healthy adults. J Magn Reson Imaging (2010) 1.09
Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour. Mol Pathol (2001) 1.09